Chris Kresser: Personally, I don’t put a lot of stock into sigA as a marker for determining a specific intervention. I think I said this in the presentations. SigA tends to just be a reflection of other pathologies. I we talked about how Candida and other fungi can reduce sigA level, so it’s very common to see fungal overgrowth markers on stool or organic acids and see low sigA along with that. It’s common to see high sigA in patients with parasites or other gut dysbiosis or issues, which reflects there may be an active gut immune response. There’s not much diagnostic value that sigA adds above and beyond all of those other things apart from telling you that something’s not quite right, and sigA will typically improve as the treatment progresses. It will typically go down if it’s up, or it will come up if it’s low, and there’s not specific actions that you take to lower sigA or increase sigA in most cases unless, as you mentioned, the patient is immunocompromised in some way and just has a decreased ability overall to produce not only IgA but also IgG and IgM maybe IgE. That’s kind of a different concern because you want to look into what conditions can cause that chronic infection or genetic issue that can lead to low immunoglobulin production. Certainly, some more serious issues can lead to that as well. I would be looking, if this were my daughter, I’d be looking at other things like fungal overgrowth, dysbiosis, or SIBO or things that could cause a change in sigA, especially because she has symptoms that reflect that.